目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF STUDY
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY
1.5 STUDY LIMITATIONS
1.6 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 ECONOMIC RECESSION IMPACT ON BRAIN MONITORING MARKET

2 RESEARCH METHODOLOGY
2.1 RESEARCH APPROACH
2.2 RESEARCH DESIGN
2.2.1 SECONDARY RESEARCH
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY RESEARCH
2.2.2.1 Key data from primary sources
2.2.2.2 key insights from primary experts
2.2.2.3 Breakdown of primaries
2.3 MARKET SIZE ESTIMATION
2.4 DATA TRIANGULATION APPROACH
2.5 MARKET SHARE ANALYSIS
2.6 ASSUMPTIONS FOR THE STUDY
2.6 RISK ASSESSMENT
2.8 MARKET LIMITATIONS
2.8.1 METHODOLOGY-RELATED LIMITATIONS
2.8.2 PRIMARY RESEARCH SCOPE REALTED LIMITATIONS
2.9 RESEARCH APPROACH FOR RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.3 INDUSTRY TRENDS
5.4 VALUE CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.7 TARIFF & REGULATORY ANALYSIS
5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES & OTHER ORGANIZATIONS
5.7.2 REGULATORY TRENDS
5.8 PORTERS FIVE FORCES ANALYSIS
5.9 PATENT ANALYSIS
5.9.1 PATENT PUBLICATION TRENDS FOR BRAIN MONITORING
5.9.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.1 PRICING ANALYSIS
5.10.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.10.2 AVERAGE SELLING PRICE TREND, BY REGION
5.11 TRADE ANALYSIS
5.13 KEY CONFERENCES & EVENTS (2023-2025)
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.15 UNMET NEEDS - BRAIN MONITORING MARKET
5.15.1 KEY STAKEHOLDERS & KEY PARAMETERS
5.15.2 END USER EXPECTATIONS
5.17 REIMBURSEMENT SCENARIO
5.18 CASE STUDIES
5.19 BRAIN MONITORING BUSINESS MODELS
5.2 BRAIN MONITORING INVESTMENT LANDSCAPE

6 BRAIN MONITORING MARKET, BY PRODUCT
6.1 INTRODUCTION
6.2 BY DEVICES
6.2.1 ELECTROENCEPHALOGRAPH
6.2.2 TRANSCRANIAL DOPPLER
6.2.3 MAGNETOENCEPHALOGRAPH
6.2.4 INTRACRANIAL PRESSURE MONITOR
6.2.5 CEREBRAL OXIMETER
6.2.6 MRI (INCLUDES FMRI TOO)
6.2.7 CT
6.2.8 PET
6.2.9 SLEEP MONITORING DEVICES
6.2.10 ELECTROMAYOGRAPHY DEVICES
6.3 BY ACCESSORIES
6.3.1 BY TYPE
6.2.2.1 ELECTRODES
6.2.2.2 SENSORS
6.2.2.3 PASTES AND GELS
6.2.2.4 CAPS
6.2.2.5 CABLES
6.2.2.6 BATTERIES
6.2.2.7 OTHERS
6.3.2 BY USABILITY
6.3.2.1 DISPOSABLE
6.3.2.2 NON-DISPOSABLE

7 BRAIN MONITORING MARKET, BY PROCEDURE
7.1 INTRODUCTION
7.2 INVASIVE
7.3 NON-INVASIVE

8 BRAIN MONITORING MARKET, BY MODALITY
8.1 INTRODUCTION
8.2 FIXED
8.3 PORTABLE
8.4 WEARABLE

9 BRAIN MONITORING MARKET, BY MEDICAL CONDITION
9.1 INTRODUCTION
9.2 TRAUMATIC BRAIN INJURIES
9.3 STROKE
9.4 DEMENTIA
9.5 HEADACHE DISORDERS
9.6 SLEEP DISORDERS
9.7 EPILEPSY
9.8 PARKINSON'S DISEASE
9.9 HUNTINGTON'S DISEASE
9.1 OTHER THERAPEUTIC APPLICATIONS

10 BRAIN MONITORING MARKET, BY END USER
10.1 INTRODUCTION
10.2 HOSPITALS
10.3 NEUROLOGICAL CENTERS
10.5 DIAGNOSTIC CENTERS
10.6 ASCS & CLINICS
10.7 OTHERS

11 REMOTE PATIENT MONITORING MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
11.2.2 US
11.2.3 CANADA
11.3 EUROPE
11.3.1 EUROPE: IMPACT OF ECONOMIC RECESSION
11.3.2 GERMANY
11.3.3 UK
11.3.4 FRANCE
11.3.5 ITALY
11.3.6 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
11.4.2 JAPAN
11.4.3 CHINA
11.4.4 INDIA
11.4.5 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
11.5.2 BRAZIL
11.5.3 MEXICO
11.4.4 REST OF LATIN AMERICA
11.6 MIDDLE EAST AND AFRICA
11.6.1 GCC COUNTRIES
11.6.2 MIDDLE EAST AND AFRICA: IMPACT OF ECONOMIC RECESSION

12 COMPETITIVE LANDSCAPES
12.1 OVERVIEW
12.2 STRATEGIES ADOPTED BY KEY PLAYERS
12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
12.4 MARKET SHARE ANALYSIS
12.5 COMPANY EVALUATION QUADRANT FOR KEY PLAYERS
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPANY FOOTPRINT
12.6 COMPANY EVALUATION QUADRANT FOR START-UPS/SMES
12.6.1 PROGRESSIVE COMPANIES
12.6.2 DYNAMIC COMPANIES
12.6.3 STARTING BLOCKS
12.6.4 RESPONSIVE COMPANIES
12.6.5 COMPETITIVE BENCHMARKING
12.7 COMPETITIVE SCENARIO

13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 NATUS MEDICAL INC.
13.1.2 NIHON KOHDEN CORPORATION
13.1.3 PHILIPS HEALTHCARE
13.1.4 SIEMENS HEALTHINEERS
13.1.5 COMPUMEDICS LIMITED
13.1.6 MEDTRONIC PLC
13.1.7 EDWARDS LIFESCIENCES
13.1.8 ADVANCED BRAIN MONITORING INC.
13.1.9 DRÄGERWERK AG & CO. KGAA
13.1.10 MASIMO CORPORATION
13.1.11 LUCIOLE MEDICAL AG
13.1.12 CADWELL INDUSTRIES INC.
13.1.13 NEUROWAVE SYSTEMS INC.
13.1.14 NEUROSOFT
13.1.15 CGX
13.1.16 INTEGRALIFESCIENCES
13.1.17 NONIN
13.1.18 UNILABS HOLDING AB
13.1.19 NEUSOFTMEDICALSYSTEMS
13.1.20 EMOTIV
13.2 OTHER PLAYERS
13.2.1 INFRASCAN,INC.
13.2.2 CLINICAL SCIENCE SYSTEMS
13.2.3 NORAXON
13.2.4 STERNMED
13.2.5 CERIBELL

14 APPENDIX
14.1 INSIGHTS OF INDUSTRY EXPERTS
14.2 DISCUSSION GUIDE
14.3 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.4 AVAILABLE CUSTOMIZATIONS
14.5 RELATED REPORTS
14.6 AUTHOR DETAILS